Status: Not yet recruiting
Cilostazol for Prevention of Recurrent Stroke Trial
The goal of this clinical trial is to learn whether adding cilostazol to aspirin or clopidogrel prevents stroke and heart attack in people who have had a stroke or mini-stroke.
Participants needed: 2,000
Trial details
Phase: Phase 3Age: 40+Biological sex: AllType: InterventionalSponsor: Stanford UniversityUpdated: Sep 16, 2025Locations: 1
Eligibility criteria
Diagnosis of stroke or mini-stroke (also called TIA) within the last 180 days [+1]
Had a spontaneous brain bleed within the last 2 years. [+2]